Skadden is advising Edwards Lifesciences, while Ropes & Gray is providing legal counsel to BD on the deal. Edwards Lifesciences has entered into a definitive agreement...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Sound Physicians in the transaction. Sound Physicians, a leading provider of physician services in the post-acute care setting, announced a liability management...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented LifeStance Health Group and the selling stockholders in the offering, and Kirkland & Ellis represented the underwriters. LifeStance Health Group, Inc. (“LifeStance”...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Adaptimmune Therapeutics on the transaction. Adaptimmune Therapeutics (NASDAQ: ADAP) announced it has entered into a clinical collaboration agreement with Galapagos NV (Euronext...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented Cushman & Wakefield plc in the offering, and Ropes & Gray represented the underwriter. Cushman & Wakefield plc (NYSE: CWK) (“Cushman &...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised NSTAR Electric on the offering, and Choate, Hall & Stewart advised the underwriters. NSTAR Electric, a wholly-owned subsidiary of Eversource Electric, announced...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Eversource Energy on the offering, and Choate, Hall & Stewart represented the underwriters. Eversource Energy (NYSE: ES) announced its offering of $1.4...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised initial purchasers on the offering. Morgan Stanley Direct Lending Fund announced its offering of $350 million in aggregate principal amount of its...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Nona Biosciences on the deal. Nona Biosciences announced it has entered into a license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for preclinical monoclonal...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Takeda Pharmaceuticals on the deal. Takeda Pharmaceuticals announced it has entered into a collaboration and exclusive license agreement with Degron Therapeutics (“Degron”)...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Bain Capital on the deal. Bain Capital announced the refinancing of BCPE Centur Investments, LP, the majority shareholder of Classys, a South...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Foghorn Therapeutics Inc. on the offering, and Latham & Watkins advised the underwriters. Foghorn Therapeutics Inc. (Nasdaq: FHTX) (“Foghorn”), a clinical-stage biotechnology...
You must be a Standard 1 Year member to access this content.
